Clinical Trials Insight: 700028319
Latest Information Update: 11 Jun 2008
At a glance
- Drugs IPH 1101 (Primary) ; Interleukin-2
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Innate Pharma
- 23 May 2008 Results will be presented at the Gamma Delta T cell conference in Marseille according to an Innate Pharma media release.
- 23 May 2008 Results have been reported in an Innate Pharma media release.
- 23 May 2008 Primary efficacy endpoint not reached according to an Innate Pharma media release.